Results
625
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
625 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
RHM | €1,119.00 | -2.2% | 169.3% | €48.6b | €1,203.57 | PE70.9x | E30.5% | 0.5% | Capital Goods | ||
ALNY | US$233.07 | -4.3% | 56.3% | US$31.7b | US$304.61 | PS13.4x | E58.6% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$141.24 | -16.8% | 6.5% | US$48.9b | US$197.71 | PE71.5x | E42.5% | 3.2% | Diversified Financials | ||
NVDA | US$106.98 | -6.2% | 24.7% | US$2.7t | US$171.77 | PE35.8x | E20.0% | 0.04% | Semiconductors | ||
600760 | CN¥46.31 | 3.2% | 19.2% | CN¥124.5b | CN¥53.90 | PE51.9x | E29.4% | 0.6% | Capital Goods | ||
9992 | HK$119.60 | 10.0% | 410.0% | HK$148.7b | HK$104.16 | PE97x | E38.1% | 0.2% | Retail | ||
6181 | HK$693.00 | 29.1% | n/a | HK$103.4b | HK$533.22 | PE134.9x | E43.7% | n/a | Consumer Durables | ||
NU | US$10.12 | -3.3% | -12.4% | US$52.1b | US$14.43 | PB6.4x | E24.5% | n/a | Banks | ||
SIG | AU$2.80 | -4.4% | n/a | AU$33.4b | AU$2.58 | PE59.7x | E30.0% | n/a | Healthcare | ||
300308 | CN¥101.78 | -0.7% | -13.6% | CN¥113.1b | CN¥188.47 | PE21.7x | E29.3% | 0.3% | Tech | ||
ALAB | US$61.70 | -8.8% | n/a | US$10.9b | US$125.03 | PS25.2x | E61.1% | n/a | Semiconductors | ||
WTC | AU$86.14 | -4.3% | -11.4% | AU$29.1b | AU$120.19 | PE93.5x | E25.6% | 0.2% | Software | ||
2345 | NT$632.00 | -7.2% | 32.9% | NT$362.7b | NT$870.00 | PE36.3x | E33.7% | 1.6% | Tech | ||
A012450 | ₩681,000.00 | -2.9% | 230.9% | ₩31.9t | ₩655,250.00 | PE45.8x | E31.3% | 0.3% | Capital Goods | ||
A196170 | ₩370,000.00 | -7.5% | 91.2% | ₩19.8t | ₩565,000.00 | PS265.1x | E140.6% | n/a | Pharmaceuticals & Biotech | ||
SOLARINDS | ₹9,837.10 | 9.6% | 27.2% | ₹890.2b | ₹11,447.00 | PE79.3x | E24.7% | 0.09% | Materials | ||
BAM | CA$67.71 | -15.8% | 19.8% | CA$112.7b | CA$76.40 | PE139.9x | E67.5% | 3.7% | Diversified Financials | ||
ITCI | US$131.25 | -0.02% | 100.6% | US$14.0b | US$132.00 | PS20.5x | E50.7% | n/a | Pharmaceuticals & Biotech | ||
AKBNK | ₺73.90 | 1.2% | 72.7% | ₺384.3b | ₺90.71 | PB1.6x | E45.8% | 2.6% | Banks | ||
PME | AU$229.19 | -11.6% | 130.3% | AU$26.7b | AU$254.50 | PE243.7x | E23.7% | 0.2% | Healthcare | ||
600989 | CN¥17.43 | 3.9% | 14.3% | CN¥127.3b | CN¥21.74 | PE20.3x | E38.5% | 1.6% | Materials | ||
SYM | US$21.17 | 0.6% | -53.0% | US$13.7b | US$34.20 | PS1.2x | E84.6% | n/a | Capital Goods | ||
DUOL | US$277.18 | -6.1% | 24.5% | US$13.4b | US$383.58 | PE141.6x | E37.0% | n/a | Consumer Services | ||
BAJFINANCE | ₹8,342.60 | -3.3% | 29.7% | ₹5.2t | ₹8,664.82 | PE32.3x | E23.4% | 0.4% | Diversified Financials |